Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy

Anna Johansson, Stina Häggström Rudolfsson, Peter Hammarsten, +8

American Journal Of Pathology

OncologyMedicinePathologyProstatic DiseaseCancer Biology +4

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers

Christina Hägglöf, Peter Hammarsten, Kerstin Strömvall, +5

PLoS ONE

ImmunologyPathologyStromal BiomarkersTmprss2-erg Gene FusionVascular Density +17

Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15

Francesca Bruzzese, Christina Hägglöf, Alessandra Leone, +10

Cancer Research

A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer

Sui Chu Chung, Peter Hammarsten, Andreas Josefsson, +7

European Journal of Cancer

Cannabis UseUrologyHealth SciencesFunctional SelectivityDisease Severity +8

Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival

Christina Hägglöf, Peter Hammarsten, Andreas Josefsson, +4

PLoS ONE

Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable Outcome

Andreas Josefsson, Hani Adamo, Peter Hammarsten, +6

American Journal Of Pathology

UrologyPerineural InvasionGenitourinary CancerTumor GrowthSurgical Pathology +8

Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4

Lina Thors, Anders Bergh, Emma Persson, +5

PLoS ONE

Androgen‐insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen‐dependent prostate environment

Sofia Halin Bergström, Peter Hammarsten, Pernilla Wikström, +1

The Prostate

Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients

Peter Hammarsten, Amar Karalija, Andreas Josefsson, +6

Clinical Cancer Research

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

Peter Hammarsten, Andreas Josefsson, Elin Thysell, +9

Modern Pathology

Tumor BiologyUrologySurgical OncologyRelevant SubgroupsGenitourinary Cancer +11